Skip Navigation

Journal of Antimicrobial Chemotherapy 2009 64(Supplement 1):i3-i10; doi:10.1093/jac/dkp256
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hawkey, P. M.
Right arrow Articles by Jones, A. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hawkey, P. M.
Right arrow Articles by Jones, A. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

This article appears in the following Journal of Antimicrobial Chemotherapy issue: Aspects of Antimicrobial Resistance [View the issue table of contents]

Articles

The changing epidemiology of resistance

Peter M. Hawkey1,2,* and Annie M. Jones3

1 Health Protection Agency, West Midlands Public Health Laboratory, Heart of England NHS Foundation Trust, Birmingham B5 9SS, UK 2 School of Immunology and Infection, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK 3 Magus Strategic Communications Ltd, Marr House, Scagglethorpe, Malton YO17 8ED, UK


* Corresponding author. Tel: +44-121-424-1240; E-mail: peter.hawkey{at}heartofengland.nhs.uk

Antibiotic resistance is now a linked global problem. Dispersion of successful clones of multidrug resistant (MDR) bacteria is common, often via the movement of people. Local evolution of MDR bacteria is also important under the pressure of excessive antibiotic use, with horizontal gene transfer providing the means by which genes such as blaCTX-M spread amongst different bacterial species and strains. β-Lactamase production is a common resistance mechanism in Gram-negative bacteria, and the rapid dissemination of novel genes reflects their evolution under the selective pressure of antibiotic usage. Many Enterobacteriaceae now carry broad-spectrum β-lactamases such as CTX-M, with particular genotypes associated with different geographical regions. The spread of these enzymes has compromised the clinical utility of a number of β-lactam classes and with the spread of genes such as blaKPC, carbapenems may be increasingly compromised in the future. High-level fluoroquinolone resistance (mainly caused by gyrA mutations) has also been shown to be associated with CTX-M and CMY-type enzymes, commonly due to co-carriage on conjugative plasmids of the gene for the aminoglycoside-inactivating enzyme AAC-61-Ib-cr and qnr genes (which confer low-level resistance), allowing the easy selection of gyrA mutants in the host strain. Resistance in Gram-positive bacteria is also widely distributed and increasing, with the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) blurring the distinction between hospital and community strains. Antibiotic use and environmental factors all have a role in the emergence and spread of resistance. This article reviews some of the new mechanisms and recent trends in the global spread of MDR bacteria.

Keywords: ESBLs , carbapenemases , Gram-positive bacteria , Gram-negative bacteria


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
D. Morris, F. Boyle, V. Buckley, L. Xu, B. Hanahoe, P. Hawkey, and M. Cormican
CTX-M enzymes are the predominant extended-spectrum {beta}-lactamases produced by Enterobacteriaceae in Ireland
J. Antimicrob. Chemother., October 1, 2009; 64(4): 864 - 866.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.